Becton Dickinson And Company Stock News

Harbor Investment Advisory LLC trimmed its holdings in shares of Becton, Dickinson and Company (NYSE:BDX) by 29.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,854 shares of the medical instruments suppliers stock after selling 786 shares during the []

Webster Bank N. A. lifted its stake in Becton, Dickinson and Company (NYSE:BDX) by 1.3% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 11,445 shares of the medical instruments suppliers stock after acquiring an additional 148 shares during the period. Webster Bank N. A.s holdings []

Related Stocks: GPN , PYPL , CSCO , BDX ,

Becton, Dickinson and (NYSE:BDX) issued an update on its FY 2022 earnings guidance on Thursday morning. The company provided earnings per share guidance of $12.300-$12.500 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.400. The company issued revenue guidance of $19.30 billion-$19.50 billion, compared to the consensus revenue estimate []

Becton, Dickinson is one of the most stable predictable low-volatility health care stocks out there.

DUBLIN--(BUSINESS WIRE)--The "Polymerase Chain Reaction Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global polymerase chain reaction market exhibited strong growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of around 8% during 2021-2026. Companies Mentioned Agilent Technologies Inc. BD (Becton Dickinson and Company) BioMerieux (Institut Merieux SA) Bio-RA

Private Trust Co. NA lifted its holdings in shares of Becton, Dickinson and Company (NYSE:BDX) by 11.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,519 shares of the medical instruments suppliers stock after buying an additional 745 shares during the []

Related Stocks: ROKU , KO , SBUX , CI , STZ , PRU , QQQM , MGK , V , DUK , FIS , ZBH , VIAC , BAH , INCY , SWKS , LSXMK , BDX ,

Bath Savings Trust Co reduced its position in shares of Becton, Dickinson and Company (NYSE:BDX) by 63.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,747 shares of the medical instruments suppliers stock after selling 11,857 shares during the period. []

Confluence Investment Management LLC cut its position in shares of Becton, Dickinson and Company (NYSE:BDX) by 16.2% in the third quarter, HoldingsChannel reports. The firm owned 85,777 shares of the medical instruments suppliers stock after selling 16,605 shares during the period. Confluence Investment Management LLCs holdings in Becton, Dickinson and were worth $21,086,000 as of []

Investors saw a few very good dividend increases in the first half of November, with ADP, Snap-on, and Roper Technologies announcing double-digit boosts, and a massive 29% boost from HP. The second ha

Shares of Becton, Dickinson and Company (NYSE:BDX) have received a consensus recommendation of Buy from the eleven brokerages that are presently covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year target price among analysts []

According to Stratagem Market Insights'' latest report, the Global Histology and Cytology Market is projected to develop at a rapid pace from 2021 to 2028. During the forecast period, the report proposes to estimate market share in terms of volume.

In this article series, we provide a weekly summary of dividend changes. A summary table presents relevant data and key statistics of dividend increases.

IMF October Buys: The 13 Stocks Added To My Fund